The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting.|https://dx.doi.org/10.3390/microorganisms11092182
Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.|https://dx.doi.org/Unknown DOI
CE: Current and Emerging Applications of Fecal Microbiota Transplantation.|https://dx.doi.org/10.1097/01.NAJ.0000978920.88346.77
Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.2147/PPA.S415681
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.|https://dx.doi.org/10.1007/s11894-023-00890-9
Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile.|https://dx.doi.org/10.1038/s41598-023-41128-y
Systems-ecology designed bacterial consortium protects from severe Clostridioides difficile infection.|https://dx.doi.org/10.1101/2023.08.08.552483
Therapeutics for Clostridioides difficile infection: molecules and microbes.|https://dx.doi.org/10.1080/17474124.2023.2250716
Recurrent Multidrug-Resistant Clostridium difficile Infection Secondary to Ulcerative Colitis a Case Report.|https://dx.doi.org/10.3390/medsci11030052
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn's Disease: A Systematic Review.|https://dx.doi.org/10.7759/cureus.42120
Gut microbiome and its clinical implications: exploring the key players in human health.|https://dx.doi.org/10.1097/QCO.0000000000000958
